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In this case, our patient was a heart transplant candidate connected to a respiratory system. An extracorporeal
biventricular assist device (BIVAD) was the only option in order to bridge to transplantation. In routine procedures,
it is recommended that Berlin Heart Excor cannulas be removed through the subfascial subcostal tunnel. As the
severely dilated right ventricle compressed the apex of the left ventricle, which was also dilated to the mid-back
zone of the left hemithorax, the whole length of the Extracorporeal BIVAD apical cannula had to remain within the
thorax; however, the cannula was removed from the body by creating a tunnel at the 7th intercostal space. In the
long-term follow-up, this compulsory modification has proven to be safe and effective.
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Today, heart transplantation in patients with severe heart
failure can be performed worldwide, and its results have
reached an encouraging level. The number of patients
waiting for transplantation is increasing day by day; how-
ever, the shortage of donors still remains a common prob-
lem. The use of VAD as a bridge to transplantation, due to
a shortage of donors, is expanding with the transition of
these patients into the decompensated heart failure stage,
resistant to pharmacological treatment [1]. In VAD pa-
tients, left ventricular (LV) inflow cannula is usually re-
moved from the body with subcostal incisions through the
costal margin, adjacent to the diaphragm. In patients with
severely dilated LV, such as a dilated cardiomyopathy
(DCM), removal of the LV inflow cannula from the body is
difficult surgically [2]. In this article, we will present a case
with DCM (New York Heart Association (NYHA) class V),
who was a heart transplantation candidate requiring an
emergency BIVAD as a bridge to transplantation. The main
point of this letter is to demonstrate the safety and effect-
iveness of this modification in long term follow up.* Correspondence: albayrakg@hotmail.com
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Our patient was a 51-year-old Caucasian male under
follow-up with the diagnosis of New York Heart Associ-
ation (NYHA) class V dilated cardiomyopathy. Two dimen-
sional echocardiography revealed left ventrical ejection
fraction (LVEF): 15%, right ventrical ejection fraction
(RVEF): 20%, left ventricular dilatation, systolic diastolic
dysfunction, moderate mitral valve insufficiency, severe tri-
cuspid insufficiency, pulmonary artery pressure: 55 mmHg/
24 mmHg and left atrial dilatation. Upon heart
catheterization, the right atrial pressure and pulmonary
artery pressure were 18 mmHg and 60/26 (43) mmHg,
respectively. Pulmonary capillary wedge pressure was
21 mmHg. Calculated cardiac index was 1.8 L/min per
square meter. Coronary arteriography was normal. Accord-
ing to the results of these investigations, heart transplant-
ation was decided for the patient. The patient required
treatment at the intensive care unit (ICU) as his general
condition had deteriorated and an intra-aortic balloon
pump was applied as a bridge to the next decision. During
follow-up at the ICU, the patient suffered cardiac arrest.
Despite intensive positive inotropic support and intra-
aortic balloon pump support, systemic arterial pressure
was 65/45 mmHg. Immediately afterwards, BIVAD im-
plantation was decided for the patient.. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chest X-ray of the patient on the first postoperative day.
Figure 3 Appearance of the cannulas on CT angiography.
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was placed first. Due to cardiomegaly and the long distance
between the apex of the heart and the sternum, the apex
cannula could not be removed from the anterior abdom-
inal wall. The cannula, which was positioned on the left
ventricular apex, was pushed to middle and back of the left
hemithorax along the lateral edge of the left of the heart
and was removed from the body through the extrapleural
tunnel, placed in the 7th intercostal space (Figure 1). Can-
nulas of the right atrium, pulmonary artery, and ascending
aorta were found and removed through the tunnel under
the anterior abdominal wall (Figure 2). It was confirmed by
computerized tomography angiography that the apex can-
nula, removed through the intercostal tunnel, was not
kinked. Removal of the apex cannula from the intercostal
space had no adverse effect on the success of BIVAD, and
there was no pain due to compression of the intercostalFigure 2 Positions of the cannulas on patient.nerves. The patient became more functional at the activ-
ities of daily life one week after BIVAD implantation.
Heart transplantation was performed one year after
BIVAD implantation. Unfortunately, the patient died due to
pneumonia and sepsis in the postoperative third month.
A written informed consent form was obtained from the
patient for publication of this case report and accompany-
ing images.
Conclusion
VAD implantation is a very well known procedure for ad-
vanced stage heart failure. The exact positioning is very im-
portant when inserting the left ventricular apex cannula.
Since the cannula is placed very close to the interventricu-
lar septum or the papillary muscle, severe constraints on
flow may ensue [3]. To prevent infection and pain, it is
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moved from the body through the subfascial tunnel [4]. In
our case, it was predicted that the cannula could not be re-
moved subcostaly, under the skin, because of corbovinum
and the distance of the apex to the sternum. The apex can-
nula was removed through the intercostal space, and it was
confirmed by computerized tomography angiography that
the apex cannula was not kinked (Figure 3).
In BIVAD implantation, if the apex is not at the normal
location due to cardiomegaly, and if coiling on the cannula
is considered when the cannula is removed from subcostal
region, the apex cannula can be removed through the
intercostal space with a necessary modification.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by Editor-in-Chief of this journal.
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